A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.

Andreas PinterL J GreenJ SelmerM PraestegaardLinda F Stein Gold Matthias Augustinnull null

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)

The novel fixed dose combination CAL/BDP PAD-cream offers greater efficacy, superior patient QoL and equivalent favourable safety for the topical treatment of psoriasis, in comparison to the currently available topical suspension/gel.

Keyphrases

wound healing
open label
randomized controlled trial
coronary artery disease
double blind
case report
atopic dermatitis
combination therapy
study protocol
replacement therapy
phase iii